Retinal nerve fiber layer thickness in patients with Alzheimer sisease

Journal of Neuro-Ophthalmology

Volumn 33, Issue 1, 2013, Pages 58-61

  Kirbas, Serkan ^a   Turkyilmaz, Kemal ^a   Anlar, Omer ^a   Tufekci, Ahmet ^a   Durmus, Mustafa ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OPTIC NERVE; PRESBYOPIA; PRIORITY JOURNAL; REFRACTION ERROR; RETINA MACULA LUTEA; RETINAL NERVE FIBER LAYER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84874107781     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318267fd5f     Document Type: Article

References (17)

1. Frost S, Martins RN, Kanagasingam Y. Ocular biomarker for early detection of Alzheimer's disease. J Alzheimers Dis. 2010;22:1-16
2. Ohno-Matsu K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res. 2011;30:217-238
3. Oliveira LT, Louzada PR, Mello FG, Ferreira ST. Amyloid-b decreases nitric oxide production in cultured retinal neurons: A possible mechanism for synaptic dysfunction in Alzheimer's disease? Neurochem Res. 2011;36:163-169
4. Krasodomska K, Lubinski W, Potemkowski A, Honczarenko K. Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease. Doc Ophthalmol. 2010;121:111-121
5. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal Abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci. 2007:48;2285-2289
6. Kesler A, Vakhapova V, Korczyn AD, Naftalive E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg. 2011;113:523-526
7. Guo L, Duggan J, Corderio MF. Alzheimer's disease and retinal neurodegeneration. Curr Alzheimer Res. 2010;7:3-14
8. Pasol J. Neuro-ophthalmic disease and optical coherence tomography: Glaucoma look-alikes. Curr Opin Ophthalmol. 2011;22:124-132
9. Greenberg BM, Frohman E. Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord. 2010;3:153-160
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944
11. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198
12. Paguet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2007;420:97-99
13. Iseri PK, Altinas Ö, Tokay T, Yüksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006;26:18-24
14. Ci Y, Wang YH, Yang L. The investigation of retinal nerve fiber loss in Alzheimer's disease. Zhonghua Yan Ke Za Zhi. 2010;46:134-139
15. Armstrong RA. Visual field defects in Alzheimer's disease patients may reflect differential pathology in the primary visual cortex. Optom Vis Sci. 1996;73:677-682
16. Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54(suppl 1):S204-S217
17. Yanagisawa K. Newly approved drugs for Alzheimer disease: Effectiveness and limitation. Brain Nerve. 2011;63:863-868